Article
Host genetic background regulates the capacity for anti-tumor antibody-dependent phagocytosis
2023-05-09
Abstract excerpt
<h4>Background</h4> Antitumor antibody, or targeted immunotherapy, has revolutionized cancer treatment and markedly improved patient outcomes. A prime example is the monoclonal antibody (mAb) trastuzumab, which targets human epidermal growth factor receptor 2 (HER2). However, like many targeted immunotherapies, only a subset of patients benefit from trastuzumab long-term. In addition to tumor-intrinsic factors, w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 446bedb7-882b-57c2-b6de-d596ccfecec8
- DOI
- 10.1101/2023.05.09.540046
